Table 6 Outcomes and complications of KP between glucocorticoid users and non-glucocorticoid users in RA
Variable | Glucocorticoid users | Non-glucocorticoid users | P value | |
|---|---|---|---|---|
Glucocorticoid users/vertebrae | 65/116 | 33/42 | Â | |
Age (year) | 72.1 | 69.8 | 0.246 | |
Gender (male to female) | 5:60 | 3:30 | 0.999 | |
BMD (g/cm2) | 0.51 | 0.60 | 0.041 | |
Time to surgery | 21.24 | 20.38 | 0.382 | |
ESR (mm/h) | 33.9 | 39.6 | 0.106 | |
CRP (mg/dL) | 9.0 | 13.95 | 0.061 | |
Cement volume (mL) | 6.13 | 6.34 | 0.369 | |
Cement leakage (vertebra) | 38 (32.8%) | 5 (11.9%) | 0.009 | |
Paravertebral leakage | 15 | 3 | 0.404 | |
Intradiscal leakage | 19 | 1 | 0.027 | |
Intraspinal leakage | 3 | 2 | 0.609 | |
Refracture | 2 | 1 | 0.999 | |
Adjacent vertebral fracture | 17 | 1 | 0.044 | |
Radiological outcomes | ||||
Compression rate (%) | Preop | 58.57% | 63.05% | 0.185 |
1 year FU | 69.97% | 75.05% | 0.102 | |
Local kyphotic angel (°) | Preop | 7.86 | 8.16 | 0.344 |
1 year FU | 3.98 | 4.69 | 0.074 | |
Clinical outcomes | ||||
VAS | Preop | 8.13 | 8.07 | 0.652 |
1 year FU | 2.31 | 2.37 | 0.564 | |
ODI | Preop | 81.90 | 79.58 | 0.449 |
1 year FU | 26.78 | 28.35 | 0.506 | |